Cargando…

Novel Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Syndrome due to Insulin Therapy

Patient: Male, 67 Final Diagnosis: Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome Symptoms: Bilateral wrist swelling Medication: — Clinical Procedure: — Specialty: Rheumatology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Remitting seronegative s...

Descripción completa

Detalles Bibliográficos
Autores principales: Mainali, Naba Raj, Schmidt, Torrey R., Alweis, Richard, George, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972051/
https://www.ncbi.nlm.nih.gov/pubmed/24696753
http://dx.doi.org/10.12659/AJCR.890318
_version_ 1782309540074618880
author Mainali, Naba Raj
Schmidt, Torrey R.
Alweis, Richard
George, David L.
author_facet Mainali, Naba Raj
Schmidt, Torrey R.
Alweis, Richard
George, David L.
author_sort Mainali, Naba Raj
collection PubMed
description Patient: Male, 67 Final Diagnosis: Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome Symptoms: Bilateral wrist swelling Medication: — Clinical Procedure: — Specialty: Rheumatology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome is a rare clinical entity characterized by the sudden onset of inflammatory arthritis and marked pitting edema on upper and lower extremities. RS3PE is considered a rheumatic process distinct from rheumatoid arthritis, which may occasionally represent a paraneoplastic syndrome. CASE REPORT: Herein, we describe a rare case of RS3PE associated with insulin therapy in a patient with no evidence of underlying malignancy. CONCLUSIONS: To the best of our knowledge, this is the first case report of RS3PE associated with insulin therapy. Physicians should look at the introduction of drugs as possible triggers for the development of RS3PE.
format Online
Article
Text
id pubmed-3972051
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-39720512014-04-02 Novel Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Syndrome due to Insulin Therapy Mainali, Naba Raj Schmidt, Torrey R. Alweis, Richard George, David L. Am J Case Rep Articles Patient: Male, 67 Final Diagnosis: Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome Symptoms: Bilateral wrist swelling Medication: — Clinical Procedure: — Specialty: Rheumatology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome is a rare clinical entity characterized by the sudden onset of inflammatory arthritis and marked pitting edema on upper and lower extremities. RS3PE is considered a rheumatic process distinct from rheumatoid arthritis, which may occasionally represent a paraneoplastic syndrome. CASE REPORT: Herein, we describe a rare case of RS3PE associated with insulin therapy in a patient with no evidence of underlying malignancy. CONCLUSIONS: To the best of our knowledge, this is the first case report of RS3PE associated with insulin therapy. Physicians should look at the introduction of drugs as possible triggers for the development of RS3PE. International Scientific Literature, Inc. 2014-03-21 /pmc/articles/PMC3972051/ /pubmed/24696753 http://dx.doi.org/10.12659/AJCR.890318 Text en © Am J Case Rep, 2014 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License
spellingShingle Articles
Mainali, Naba Raj
Schmidt, Torrey R.
Alweis, Richard
George, David L.
Novel Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Syndrome due to Insulin Therapy
title Novel Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Syndrome due to Insulin Therapy
title_full Novel Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Syndrome due to Insulin Therapy
title_fullStr Novel Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Syndrome due to Insulin Therapy
title_full_unstemmed Novel Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Syndrome due to Insulin Therapy
title_short Novel Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Syndrome due to Insulin Therapy
title_sort novel development of remitting seronegative symmetrical synovitis with pitting edema (rs3pe) syndrome due to insulin therapy
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972051/
https://www.ncbi.nlm.nih.gov/pubmed/24696753
http://dx.doi.org/10.12659/AJCR.890318
work_keys_str_mv AT mainalinabaraj noveldevelopmentofremittingseronegativesymmetricalsynovitiswithpittingedemars3pesyndromeduetoinsulintherapy
AT schmidttorreyr noveldevelopmentofremittingseronegativesymmetricalsynovitiswithpittingedemars3pesyndromeduetoinsulintherapy
AT alweisrichard noveldevelopmentofremittingseronegativesymmetricalsynovitiswithpittingedemars3pesyndromeduetoinsulintherapy
AT georgedavidl noveldevelopmentofremittingseronegativesymmetricalsynovitiswithpittingedemars3pesyndromeduetoinsulintherapy